{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 135,
  "pageCount": 239,
  "prevPage": 134,
  "nextPage": 136,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Uses authority-citation framework to undermine the company's product launch.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/135",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-135",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Comments from one KOL after another were consistent and devastating in their assessment of Omnia.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b341-8249ef263684",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.06,
        "y": 0.31
      },
      "kind": "list",
      "text": "Omnia is \"an attempt to save market share with beleaguered cohort of doctors that are sick of explanting the device\" when high frequency fails",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1545bebd-f10d-456e-ab53-4f3e6c919040",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.06,
        "y": 0.51
      },
      "kind": "list",
      "text": "Even the most positive comments indicate Omnia is merely no better and no worse than other stimulators",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "24e3ff9f-531b-4965-ac2b-51032ac75b5f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.06,
        "y": 0.19
      },
      "kind": "list",
      "text": "Omnia is irrelevant, a me-too device, and not \"a game changer\"",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc57d735-21ca-4e32-b8ed-86bc47b6196f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.06,
        "y": 0.66
      },
      "kind": "list",
      "text": "Omnia is an admission of high frequency's problems and a forced move to prevent the company from going out of business",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e03e21aa-dfd6-4b98-babb-df07ed401937",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.8,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "Comments from one KOL after another were consistent and devastating in their assessment of Omnia.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "56acfcab-c0d1-4d7d-a276-842a5c74dea2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.8,
        "x": 0.1,
        "y": 0.37
      },
      "kind": "quote",
      "text": "\"So Nevro had a good idea but they failed to maintain programming options having thrown their entire emphasis behind 10,000Hz. When it was proven that 1,000Hz was equal in efficacy, Nevro quaked in their boots. The Omnia is an attempt to save market share with a beleaguered cohort of doctors that are sick of explanting the device when the 10,000 Hz programming fails to work.\" –KOL, former high volume Nevro user",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1518ae6d-37f4-4eb6-bbf5-4bf196487b06",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.1,
        "y": 0.56
      },
      "kind": "quote",
      "text": "\"Omnia has burst, tonic, HF10, intermediate frequencies, and you can use multiple programs. When it came out, if one program doesn't work, I can change to another. I've started using it. It hasn't been any better than Boston Scientific but it works.\"–KOL and high volume implanter",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69dea7c7-c6a5-41a5-9fa3-591ec53ade2c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.8,
        "x": 0.1,
        "y": 0.23
      },
      "kind": "quote",
      "text": "\"I don't think Omnia matters. All of the other manufacturers are pretty much doing the same thing with their batteries. It's not a game changer.\" – KOL in the SCS field with prominent papers published",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad9dacf1-93d4-44d0-b308-af1f8a0b1619",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.8,
        "x": 0.1,
        "y": 0.72
      },
      "kind": "quote",
      "text": "\"If HF10 was as groovy as they thought it was, they wouldn't have had to change the device to do paresthesia. They were forced into Omnia or they would have gone out of business.\" – KOL and former high volume Nevro implanter",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b42f38a0-21f6-411c-a356-02beb4947478",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I don’t think Omnia matters. All of the other manufacturers are pretty much doing the same thing with their batteries. It’s not a game changer. — KOL in the SCS field with prominent papers published; So Nevro had a good idea but they failed to maintain programming options having thrown their entire emphasis behind 10,000Hz. When it was proven that 1,000Hz was equal in efficacy, Nevro quaked in their boots. The Omnia is an attempt to save market share with a beleaguered cohort of doctors that are sick of explanting the device when the 10,000 Hz programming fails to work. — KOL, former high volume Nevro user; Omnia has burst, tonic, HF10, intermediate frequencies, and you can use multiple programs. When it came out, if one program doesn’t work, I can change to another. I’ve started using it. It hasn’t been any better than Boston Scientific but it works. — KOL and high volume implanter; If HF10 was as groovy as they thought it was, they wouldn’t have had to change the device to do paresthesia. They were forced into Omnia or they would have gone out of business. — KOL and former high volume Nevro implanter",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b341-864cfb3ad59a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.06,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35b57542-3411-46ff-8df2-64dfe6493444",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "10. The new Omnia stimulator, the centerpiece of Nevro's turnaround hopes, is a Hail Mary and colossal flop",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4adadc19-4b6c-4a58-9006-590d6745b9d4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "369dbfac-b7a8-4830-bd14-ae3198334b3b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "d919fe73-d2af-4469-b3ac-d02a07defd1a",
      "evidence": "Uses multiple KOL quotes to validate the thesis.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}